FDA Inspection 926808 — Takeda Austria GmbH

Takeda Austria GmbH — FEI 3001157285

The FDA completed an inspection of Takeda Austria GmbH on May 28, 2015 in Linz. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 28, 2015
Fiscal Year
2015
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Linz (Austria)